Changing the Course of Alzheimer’s Disease: New Biomarkers to Improve Diagnostic Precision

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.
For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/APA information, and to apply for credit, please visit us at PeerView.com/XXK865. CME/MOC/AAPA/APA credit will be available until November 8, 2025.
CASCADE™-Changing the Course of Symptomatic Alzheimer's Disease Early: Moving Research to the Real World With New Biomarkers to Improve Diagnostic Precision
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Lilly.
Disclosure information is available at the beginning of the video presentation.